UN Panel To Hear Stakeholder Ideas On IP, Innovation And Access
This article was originally published in Scrip
Executive Summary
Later this month, the UN high-level panel on access to medicines will hold public hearings to discuss the ideas it has received from stakeholders on how best to ensure access to affordable and high-quality drug treatment while continuing to encourage innovation and the development of new medicines, vaccines and diagnostics.